Want to track 4519 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Chugai Pharmaceutical Co., Ltd. (4519) Statistics
Valuation metrics
Market Cap 13.78T
Enterprise value 11.04T
Trailing P/E (ttm) 24.2
Forward P/E 35.39
PEG ratio 1.26
Price/Sales (ttm) 8.5
Price/Book (mrq) 5.63
Enterprise Value/Revenue 8.22
Enterprise Value/EBITDA 16.03
Overview
Shares outstanding 1.65B
Float 639.89M
Shares short -
% Held by insiders 0.6%
% Held by institutions 0.19%
Average volume (10 days) 3.3M
Average volume (90 days) 2.44M
Price summary
52-Week low 5,942
52-Week high 10,700
Beta 0.6
50-Day moving average 7,364.69
200-Day moving average 8,298.21
Dividends and splits
Forward annual dividend rate 294
Forward annual dividend yield 0.0332%
Trailing annual dividend rate 213
Trailing annual dividend yield 0.0307%
5-Year annual dividend yield 1.66%
Payout ratio 0.95
Dividend Date 29 Jun 2026
Ex-Dividend Date 29 Jun 2026
Last split factor 3:1
Last split Date 29 Jun 2020
Financials
Fiscal year
Fiscal year ends 31 Dec 2025
Most recent quarter (mrq) 31 Mar 2025
Profitability
Profit margin 0.35%
Operating margin 0.47%
Operational effectiveness
Return on assets 0.19%
Return on equity 0.24%
Income Statement
Revenue (ttm) 1.26T
Revenue per share (ttm) 816
Quarterly revenue growth (yoy) 0.15%
Gross profit (ttm) 894.25B
EBITDA 598.01B
Net income to common (ttm) 434.01B
Diluted EPS (ttm) 286.44
Quarterly earnings growth (yoy) 0.4%
Balance Sheet
Total cash (mrq) 979.7B
Total cash per share (mrq) 584.94
Total debt (mrq) 25.71B
Total Debt/Equity (mrq) 0.01
Current ratio (mrq) 4.35%
Book value per share (mrq) 1,232.17
Cash Flow
Cash flow statement 386.28B
Levered free cash flow (LFCF) 263.05B
